Determinants of radical prostatectomy in the prostate, lung, colorectal, ovarian (PLCO) cancer screening trial

被引：0
|
作者：
Miller, David C.
Church, Timothy R.
Hickey, Thomas
Greenlee, Robert T.
Lzmirlian, Grant
Mabie, Jerome
Riley, Thomas L.
Ragard, Lawrence
Prorok, Philip C.
Berg, Christine D.
Crawford, E. David
Andriole, Gerald L.
Grubb, Robert L.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60090-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial - Preface
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 249S - 250S
  • [2] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S
  • [3] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10) : 722 - 731
  • [4] Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Stallings, FL
    Ford, ME
    Simpson, NK
    Fouad, M
    Jernigan, JC
    Trauth, JM
    Miller, DS
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 379S - 389S
  • [5] Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Pinsky, Paul F.
    Black, Amanda
    Parnes, Howard L.
    Grubb, Robert
    Crawford, E. David
    Miller, Anthony
    Reding, Douglas
    Andriole, Gerald
    [J]. CANCER EPIDEMIOLOGY, 2012, 36 (06) : E401 - E406
  • [6] Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial
    Miller, Eric A.
    Pinsky, Paul F.
    Black, Amanda
    Andriole, Gerald L.
    Pierre-Victor, Dudith
    [J]. PROSTATE, 2018, 78 (11): : 830 - 838
  • [7] Measuring the impact of HIPAA in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
    Marcus, PM
    Miedzinksi, M
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (02) : 549 - 549
  • [8] Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Miller, AB
    Yurgalevitch, S
    Weissfeld, JL
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 400S - 406S
  • [9] The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource
    Zhu, Claire S.
    Huang, Wen-Yi
    Pinsky, Paulf F.
    Berg, Christine D.
    Sherman, Mark
    Yu, Kelly J.
    Carrick, Danielle M.
    Black, Amanda
    Hoover, Robert
    Lenz, Petra
    Williams, Craig
    Hawkins, Laura
    Chaloux, Matthew
    Yurgalevitch, Susan
    Mathew, Sunitha
    Miller, Amy
    Olivo, Vanessa
    Khan, Asia
    Pretzel, Shannon M.
    Multerer, Deborah
    Beckmann, Patricia
    Broski, Karen G.
    Freedman, Neal D.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (12) : 1635 - 1642
  • [10] Effectiveness of nurse endoscopists in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial
    Bresalier, RS
    Pinsky, P
    Weissfeld, J
    Schoen, R
    Church, T
    Yokochi, L
    Prorok, P
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A479 - A479
12345